These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23538192)

  • 1. Mapping EQ-5D utility scores from the Incontinence Quality of Life Questionnaire among patients with neurogenic and idiopathic overactive bladder.
    Kay S; Tolley K; Colayco D; Khalaf K; Anderson P; Globe D
    Value Health; 2013; 16(2):394-402. PubMed ID: 23538192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping of incontinence quality of life (I-QOL) scores to assessment of quality of life 8D (AQoL-8D) utilities in patients with idiopathic overactive bladder.
    Chen G; Tan JT; Ng K; Iezzi A; Richardson J
    Health Qual Life Outcomes; 2014 Aug; 12():133. PubMed ID: 25174274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping the SRS-22r questionnaire onto the EQ-5D-5L utility score in patients with adolescent idiopathic scoliosis.
    Wong CKH; Cheung PWH; Samartzis D; Luk KD; Cheung KMC; Lam CLK; Cheung JPY
    PLoS One; 2017; 12(4):e0175847. PubMed ID: 28414745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping of the OAB-SF Questionnaire onto EQ-5D in Spanish Patients with Overactive Bladder.
    Ruiz MA; Gutiérrez LL; Monroy M; Rejas J
    Clin Drug Investig; 2016 Apr; 36(4):267-79. PubMed ID: 26860486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating EQ-5D and OAB-5D health state utilities for patients with overactive bladder.
    Desroziers K; Aballéa S; Maman K; Nazir J; Odeyemi I; Hakimi Z
    Health Qual Life Outcomes; 2013 Nov; 11():200. PubMed ID: 24246044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychometric properties of the incontinence utility index among patients with idiopathic overactive bladder: data from two multicenter, double-blind, randomized, Phase 3, placebo-controlled clinical trials.
    Castejón N; Khalaf K; Ni Q; Cuervo J; Patrick DL
    Health Qual Life Outcomes; 2015 Aug; 13():116. PubMed ID: 26231052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of overactive bladder on quality of life and resource use: results from Korean Burden of Incontinence Study (KOBIS).
    Lee KS; Choo MS; Seo JT; Oh SJ; Kim HG; Ng K; Lee KJ; Tan JT; Kim JC
    Health Qual Life Outcomes; 2015 Jun; 13():89. PubMed ID: 26113125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping the 25-item National Eye Institute Visual Functioning Questionnaire (NEI VFQ-25) to EQ-5D utility scores.
    Kay S; Ferreira A
    Ophthalmic Epidemiol; 2014 Apr; 21(2):66-78. PubMed ID: 24568628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping function from FACT-B to EQ-5D-5 L using multiple modelling approaches: data from breast cancer patients in China.
    Yang Q; Yu XX; Zhang W; Li H
    Health Qual Life Outcomes; 2019 Oct; 17(1):153. PubMed ID: 31615531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping MacNew Heart Disease Quality of Life Questionnaire onto country-specific EQ-5D-5L utility scores: a comparison of traditional regression models with a machine learning technique.
    Gao L; Luo W; Tonmukayakul U; Moodie M; Chen G
    Eur J Health Econ; 2021 Mar; 22(2):341-350. PubMed ID: 33438134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping ALSFRS-R and ALSUI to EQ-5D in Patients with Motor Neuron Disease.
    Moore A; Young CA; Hughes DA
    Value Health; 2018 Nov; 21(11):1322-1329. PubMed ID: 30442280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Converting Parkinson-Specific Scores into Health State Utilities to Assess Cost-Utility Analysis.
    Chen G; Garcia-Gordillo MA; Collado-Mateo D; Del Pozo-Cruz B; Adsuar JC; Cordero-Ferrera JM; Abellán-Perpiñán JM; Sánchez-Martínez FI
    Patient; 2018 Dec; 11(6):665-675. PubMed ID: 29876865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of the EQ-5D in patients with irritable bowel syndrome.
    Bushnell DM; Martin ML; Ricci JF; Bracco A
    Value Health; 2006; 9(2):90-7. PubMed ID: 16626412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D.
    Hawton A; Green C; Telford C; Zajicek J; Wright D
    Value Health; 2012 Dec; 15(8):1084-91. PubMed ID: 23244811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scale characteristics and mapping accuracy of the US EQ-5D, UK EQ-5D, and SF-6D in patients with rheumatoid arthritis.
    Wolfe F; Michaud K; Wallenstein G
    J Rheumatol; 2010 Aug; 37(8):1615-25. PubMed ID: 20551106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping EORTC QLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma.
    Proskorovsky I; Lewis P; Williams CD; Jordan K; Kyriakou C; Ishak J; Davies FE
    Health Qual Life Outcomes; 2014 Mar; 12():35. PubMed ID: 24618388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of urinary incontinence on health-related quality of life, daily activities, and healthcare resource utilization in patients with neurogenic detrusor overactivity.
    Tang DH; Colayco D; Piercy J; Patel V; Globe D; Chancellor MB
    BMC Neurol; 2014 Apr; 14():74. PubMed ID: 24708598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generating EQ-5D-5L health utility scores from BASDAI and BASFI: a mapping study in patients with axial spondyloarthritis using longitudinal UK registry data.
    Neilson AR; Jones GT; Macfarlane GJ; Pathan EM; McNamee P
    Eur J Health Econ; 2022 Nov; 23(8):1357-1369. PubMed ID: 35113270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the effects on HR-QoL of treatment for overactive bladder: a detailed analysis of EQ-5D clinical trial data for mirabegron.
    Pavesi M; Devlin N; Hakimi Z; Nazir J; Herdman M; Hoyle C; Odeyemi IA
    J Med Econ; 2013 Jul; 16(7):866-76. PubMed ID: 23647446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The validation of the Dutch OAB-q SF: An overactive bladder symptom bother and health-related quality of life short-form questionnaire.
    Groenendijk IM; Scheepe JR; Noordhoff TC; Blok BFM
    Neurourol Urodyn; 2019 Aug; 38(6):1775-1782. PubMed ID: 31215693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.